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Abstract
 
Natural killer (NK) cells protect hosts against viral pathogens and transformed cells. IL-15 is
thought to play a critical role in NK cell development, but its role in the regulation of periph-
eral NK cells is less well defined. We now find that adoptive transfer of normal NK cells into
mice lacking the high affinity interleukin (IL)-15 receptor, IL-15R
 
 
 
, surprisingly results in the
abrupt loss of these cells. Moreover, IL-15R
 
 
 
–deficient NK cells can differentiate successfully
 
in radiation bone marrow chimera bearing normal cells. Finally, adoptively transferred IL-15R
 
 
 
–
deficient NK cells survive in normal but not IL-15R
 
 
 
–deficient mice. These findings demon-
strate that NK cell–independent IL-15R
 
 
 
 expression is critical for maintaining peripheral NK
cells, while IL-15R
 
 
 
 expression on NK cells is not required for this function.
Key words: IL-15 • NK cell homeostasis • NK cell survival • NK cell development
 
Introduction
 
NK cells are innate immune cells that are cytotoxic and can
secrete cytokines such as IFN-
 
 
 
. Their primary function is
to defend the host against cells bearing altered or foreign
MHC molecules (1). Peripheral NK cells are thought to be
mature cells that do not proliferate significantly unless stim-
uli such as viral pathogens are introduced. It is unclear,
however, whether the lifespan of these cells are actively
regulated in unperturbed animals and what factors might
regulate NK cell survival.
IL-15 is a unique cytokine that plays essential roles in
regulating the homeostasis of CD8
 
 
 
 T cells, TCR
 
 
 
/
 
 
 
 
 
 in-
traepithelial lymphocytes, NKT cells, and NK cells (2–7).
This growth factor binds to a trimeric receptor comprised
of IL-15R
 
 
 
, IL-2R
 
 
 
, and 
 
 
 
c
 
 (8–12). Binding of IL-15 to
 
this receptor is mediated largely by the high affinity IL-15R
 
 
 
chain, and intracellular signals are initiated by the cytoplas-
mic portions of the IL-2R
 
 
 
, and 
 
 
 
c
 
 chains. While IL-15 is
also able to stimulate primary cells through the IL-2R
 
 
 
,
and 
 
 
 
c
 
 chains of the IL-15R in vitro (unpublished data),
the similar phenotypes of IL-15 and IL15R
 
 
 
 
 
/
 
 
 
 mice sug-
gests that most physiological IL-15 signals utilize IL-15R
 
 
 
–
bearing receptors (13, 14). 
Prior studies have suggested important roles for IL-15 in
supporting both NK precursor cell differentiation and pe-
ripheral NK cell function (15–18). During development,
IL-15 is expressed by bone marrow (BM)
 
*
 
 stromal cells and
stimulates NK cell precursors to proliferate and differentiate
into mature NK cells (19–23). The virtual absence of NK
cells in IL-2R
 
 
 
–deficient (IL-2R
 
 
 
 
 
/
 
 
 
), IL-15–deficient
(IL-15
 
 
 
/
 
 
 
), and IL-15R
 
 
 
–deficient (IL-15R
 
 
 
 
 
/
 
 
 
) mice is
consistent with the suggestion that IL-15 receptor signals
 
are critical for NK cell development. In the periphery, IL-15
mRNA expression is induced during infectious stimuli and
may regulate NK cell activation and/or proliferation (17,
18, 24). However, whether IL-15R
 
 
 
 is required for these
NK cell responses is unknown. In addition, IL-15R
 
 
 
’s po-
tential role in supporting the maintenance of peripheral
NK cells in unstimulated mice has not been examined.
The ability of IL-15 to stimulate the survival and prolif-
eration of T cells and NK cells in vitro has led to the sug-
gestion that the physiological role of IL-15 is to bind di-
rectly to these cells and induce IL-15R
 
 
 
–dependent
signals. However, IL-15 and IL-15R
 
 
 
 mRNA are both
broadly expressed by hematopoietic and nonhematopoietic
cells, so IL-15R
 
 
 
 expression on accessory cells could indi-
rectly regulate NK cell function in vivo. Furthermore, re-
cent studies of poly inosine:cytosine (poly I:C) induced by-
stander activation of CD8
 
 
 
 T cells in IL-15R
 
 
 
 
 
/
 
 
 
 mice
revealed the surprising result that IL-15R
 
 
 
 expression on
cells other than CD8
 
 
 
 T cells can regulate CD8
 
 
 
 T cell
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Abbreviations used in this paper:
 
 BM, bone marrow; CFSE, carboxyfluores-
cein diacetate succinimidyl ester.T
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proliferation (25). Thus, we have used IL-15R
 
 
 
 
 
/
 
 
 
 mice
to investigate whether and how IL-15R
 
 
 
 regulates the ho-
meostasis of mature NK cells.
 
Materials and Methods
 
Mice and Radiation BM Chimera.
 
The generation and charac-
terization of IL-15R
 
 
 
 
 
/
 
 
 
 mice has been described (14). IL-
15R
 
 
 
 
 
/
 
 
 
 mice were backcrossed to C57BL/6J mice for at least
eight generations. C57Bl/6J/SJL Ly5.2
 
 
 
 congenic mice were
purchased from JAX Laboratories. To generate radiation BM chi-
mera, individual mice were irradiated with 950 rads total body
radiation, reconstituted with 4–6 
 
 
 
 10
 
6
 
 BM cells (injected via
retroorbital vein) within 1 h of irradiation, and allowed to re-
cover for at least 8 wk before use in experiments.
 
Adoptive Transfers.
 
For adoptive transfers of mature NK cells,
splenocytes from donor mice were isolated as a single cell suspen-
sion, purified by negative depletion with anti-Ig and anti-CD4
magnetic beads (Dynal), and either labeled with carboxyfluores-
cein diacetate succinimidyl ester (CFSE), or transferred directly
into recipient mice via retroorbital vein. Cell purity was typically
12% NK cells. Each recipient mouse received 10–12 
 
 
 
 10
 
6
 
 cells
of which 
 
 
 
1 
 
 
 
 10
 
6
 
 cells were NK cells. KO NK cells were en-
riched from KO BM
 
→
 
WT chimeric spleens and the purity of
these cells was typically 2.5%. Recipient mice received 30 
 
 
 
 10
 
6
 
KO cells of which 8 
 
 
 
 10
 
5
 
 were NK cells.
CFSE labeling was performed by incubating cells with 5 nM
CFSE at room temperature in the dark. The reaction was
quenched after 10 min with 100% FCS. Cells were washed,
counted, and CFSE labeling was confirmed by flow cytometry.
5 
 
 
 
g of recombinant murine IL-15 (PeproTech) or PBS was
administered per mouse, daily for four days, via intraperitoneal
injection for NK cell proliferation studies.
 
Cellular Analyses.
 
Single cell suspensions of lymphocytes
from peripheral blood, spleens, lymph nodes, lungs, and livers
were isolated as previously described and incubated with fluores-
cently conjugated or biotinylated antibodies specific for Ly5.1,
Ly5.2, CD3, and NK1.1 (BD Biosciences/Becton Dickinson)
before analyses on a FACSCalibur™ flow cytometer and
CELLQuest™ software (14, 26). The percentage of donor NK
 
cells was calculated as a percentage of total lymphoid cell popula-
tion collected. Error bars depict one standard deviation from the
mean. CFSE-labeled NK cells were analyzed from the perito-
neum of recipient mice.
 
RT-PCR.
 
mRNA was purified as described previously (14)
from mouse spleens. Some mice received 150 ng of poly I:C via
intraperitoneal injection, and were killed 1–4 d after treatment.
RT-PCR for the secreted and non secreted IL-15 transcripts was
performed as described previously (27).
 
Results
 
NK Cell–independent IL-15R
 
 
 
 Signals Are Critical for
Maintaining NK Cells.
 
To examine the potential roles of
NK cell–independent IL-15R
 
 
 
 signals in supporting mature
NK cell homeostasis, splenic NK cells from IL-15R
 
 
 
 
 
/
 
 
 
(hereafter designated wild-type, “WT”) mice were trans-
ferred intravenously into either IL-15R
 
 
 
 
 
/
 
 
 
 (“WT”) or IL-
15R
 
 
 
 
 
/
 
 
 
 (knock-out, “KO”) Ly5 congenic mice, and the
percentages of transferred WT NK cells were studied by se-
rial peripheral blood analyses. These mice were not irradi-
ated before transfer, so radiation induced cytokines and
lymphopenia were not induced. Transferred WT CD3
 
 
 
NK1.1
 
 
 
 NK cells were found in the peripheral blood 3 h
after transfer as 
 
 
 
0.15% of peripheral blood lymphocytes in
either WT or KO mice (Fig. 1, A and B). Transferred NK
cells persisted in the blood of WT mice for up to 30 d, fall-
ing gradually below the threshold of detection (0.01% of
donor PBLs) beyond that time (Fig. 1 C). This finding is
consistent with a peripheral NK cell half-life of 
 
 
 
7 d. By
contrast, the percentage of transferred WT NK cells present
in the peripheral blood of KO mice fell dramatically over
the first 16 h after transfer, and were undetectable greater
than 72 h after transfer (Fig. 1, B and C). The half-life of the
transferred WT NK cells was thus shortened from 7 d in
WT mice to 
 
 
 
10 h in KO mice. Thus, WT NK cells are
actively maintained in the periphery of unperturbed mice,
and IL-15R
 
 
 
 is critical for mediating these signals.
Figure 1. Adoptively transferred NK cells survive signif-
icantly longer in a WT host than in a KO host. (a) Repre-
sentative FACS® plot of transferred WT NK cells in WT
(left) and KO (right) hosts. Splenic WT NK cells were
transferred intravenously into either WT or KO hosts,
congenic for the Ly5 marker. 2 d after transfer, peripheral
blood from these mice were analyzed for presence of NK
cells using antibodies against Ly5.1, Ly5.2, NK1.1, and
CD3. Events displayed are gated on donor cells among the
lymphoid gate and presented as the percentage of NK cells
among donor cells for this and all subsequent figures. (b)
Peripheral blood (PBL) analysis of adoptively transferred
WT NK cells in WT ( ) or KO ( ) mice at indicated
times after transfer. Data presented is the percentage of
transferred NK cells/total lymphoid cells collected for this
and all subsequent NK cell transfer experiments. (c) Long
term PBL analysis of adoptively transferred WT NK cells
in WT ( ) or KO ( ) mice. Data are representative of
three experiments, with three mice in each experiments.T
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IL-15R
 
 
 
 Supports NK Cell Survival, Rather than Prolifera-
tion or Homing.
 
IL-15R
 
 
 
 may support T lymphocyte
homing through the regulation of adhesion molecule ex-
pression (25, 28, 29). Hence, the dramatic loss of WT NK
cells from the peripheral blood of KO mice might reflect
differential homing of NK cells to peripheral tissues. We
thus analyzed both secondary lymphoid and nonlymphoid
tissues of recipient mice for the presence of transferred NK
cells at two and fourteen days post transfer. The percent-
ages of transferred WT NK cells found in spleens, lymph
nodes, lungs or livers from recipient mice 48 h after transfer
reflected the same trend observed in peripheral blood anal-
yses (Fig. 2). No transferred WT NK cells were found in
any peripheral tissues from KO mice 72 h after adoptive
transfer. Thus, differential homing does not account for the
loss of NK cells from the peripheral blood of KO mice. In-
stead, WT NK cells disappear entirely from KO mice.
IL-15 has been shown to support both NK cell survival
and proliferation in vitro. Thus, the loss of WT NK cells
after transfer into KO mice could reflect critical roles for
IL-15 in supporting NK cell survival or proliferation. To
distinguish between these possibilities, donor NK cells were
labeled with CFSE before transfer. Analyses of tissues and
peripheral blood from recipient WT mice revealed that
transferred cells contained mostly nondiluted CFSE for 4 d,
indicating that the transferred peripheral NK cells were non-
proliferating cells (Fig. 3 A). This observation is consistent
with prior reports that mature NK cells do not proliferate at
a significant rate in unchallenged animals (30, 31) and dem-
onstrates that our manipulation of splenic NK cells does not
induce NK cell proliferation. Considered together with the
absence of selective homing defects, the loss of WT NK cells
after transfer into KO mice is likely due to the failure of KO
mice to support survival of WT cells. Moreover, the critical
role of IL-15R
 
 
 
 in supporting NK cell survival is correlated
with IL-15R
 
 
 
 expression on cells other than NK cells.
 
Heterologous IL-15 Can Induce Peripheral NK Cell Prolifera-
tion in IL-15R
 
 
 
 
 
/
 
 
 
 Mice.
 
IL-15 may stimulate NK cell
proliferation during physiological conditions such as viral
 
infections (32, 33). As our current experiments indicate
that IL-15R
 
 
 
 expression on cells other than NK cells reg-
ulate NK cell survival, we investigated whether IL-15R
 
 
 
expression on other cells would also regulate proliferative
responses of NK cells. Thus, we coinjected recombinant
IL-15 and CFSE-labeled WT NK cells into either WT or
KO mice. Analysis of peritoneal leukocytes from these
mice 4 d after adoptive transfer revealed that transferred
NK cells diluted CFSE comparably in both WT and KO
recipients, indicating that WT peripheral NK cells can
proliferate in response to IL-15 in KO mice (Fig. 3 C).
The proportion (though not the total number) of trans-
ferred WT cells that proliferated was similar in WT and
KO mice (Fig. 3, B and C). Thus, while IL-15R
 
 
 
 expres-
sion on non-NK cells is critical for maintaining survival of
peripheral NK cells in unstimulated mice, it may not be
required for supporting IL-15–mediated proliferation of
these cells.
 
IL-15R
 
 
 
 
 
/
 
 
 
 Mice Express Normal Levels of IL-15
mRNA. As the WT NK cells transferred into KO mice
above are IL-15R  competent, and as IL-15 has been sug-
gested to play a direct role in supporting NK cell survival,
one possible explanation for the failure of WT NK cells to
survive in these mice is that KO mice elaborate less IL-15
than WT mice. IL-15 secretion is regulated both transcrip-
tionally and posttranscriptionally (34, 35). In the absence of
a reliable antibody for measuring endogenous murine IL-
15 levels, we examined mRNA levels of the preferentially
secreted isoform of IL-15 (27). These studies revealed that
IL-15 mRNA is constitutively expressed and induced by
poly I:C in splenocytes from both WT and KO mice (Fig.
4). Thus, reduced IL-15 mRNA expression does not ap-
pear to explain the inability of KO mice to support periph-
eral NK cell survival.
Hematopoietic IL-15R  Competent Cells Can Support Ma-
ture NK Cells in Chimeric Mice. The experiments above
suggest that IL-15R  expression on cells other than the
NK cells is critical for supporting the survival of mature
NK cells. IL-15R  is expressed on multiple cell types and
Figure 2. The disappearance of adoptively transferred
NK cells from peripheral blood is not due to differential
homing to specific tissues. Quantitation of adoptively
transferred WT NK cells from various tissues, (a) spleen,
(b) LN, (c) PBL, (d) peritoneum, (e) liver, (f) lung of WT
(left) or KO (right) mice 48 h after adoptive transfer.
Events displayed in histogram represent percentage of
transferred CD3  NK1.1  cells within the lymphoid
gate. Data are representative of two experiments with two
mice each.T
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the types of cells that support NK cell survival are un-
known. To determine whether IL-15R  competent he-
matopoietic cells can complement the environmental de-
fect of KO mice, we reconstituted lethally irradiated
Ly5.2  KO mice with either WT (WT BM→KO chi-
mera) or KO (KO BM→KO chimera) Ly5.1  BM precur-
sors. Analyses of radiation chimera 8 wk after reconstitu-
tion failed to reveal any residual host NK cells in these
chimera (unpublished data). WT NK cells purified from
normal Ly5.2  mice (i.e., NK cells congenic to the Ly5 ge-
notype of the reconstituting BM precursors) were then
transferred into these chimera, after which serial peripheral
blood analyses and terminal tissue analyses were performed
to quantitate the transferred WT NK cells. These studies
revealed that adoptively transferred WT NK cells survived
in WT BM→KO chimera for  30 d. By contrast, trans-
ferred WT NK cells disappeared from KO BM→KO chi-
mera within 48 h after adoptive transfer (Fig. 5). Tissue
analyses of these mice confirmed that the percentages of
NK cells in spleens, livers, and lungs all reflected the per-
centages of NK cells in the peripheral blood of these ani-
mals (unpublished data). As these WT BM→KO chimera
contain WT BM-derived hematopoietic cells in their pe-
ripheral organs, this finding demonstrates that WT hemato-
poietic cells can support survival of peripheral NK cells in
KO mice.
IL-15R  Competent Cells Support KO NK Cells in Chi-
meric Mice. If IL-15R –dependent cells play an important
role in supporting NK cell survival, then it is possible that
peripheral NK cells are absent from KO mice partly due to
the inability of these mice to support these cells in the pe-
riphery (in addition to potential defects in NK cell devel-
opment). To address this point, we used congenic KO
BM to reconstitute either lethally irradiated WT (KO
BM→WT chimera) or KO (KO BM→KO chimera) mice.
Analyses of spleens, livers, and lungs from these chimeric
mice 8 wk after reconstitution revealed that far greater per-
centages of BM derived KO NK cells were obtained from
KO BM→WT than from KO BM→KO chimera (Fig. 6).
This finding indicates that KO NK cells can differentiate
successfully in KO BM→WT chimera. Thus, WT cells can
support the differentiation and/or survival of KO NK cells.
IL-15R  Expression on NK Cells Is Not Required for Sur-
vival of Peripheral NK Cells. While IL-15R  competent
cells are critical for indirectly supporting peripheral NK
cells, the signal(s) that directly support NK cell survival in
vivo are unknown. As earlier studies suggested that IL-15
can support NK cell survival and/or proliferation by bind-
ing directly to NK cells (17, 18, 24), we investigated
whether IL-15R  expression on NK cells might also be
important for regulating NK cell survival in vivo. For these
experiments, we took advantage of the fact that KO NK
cells are present in the periphery of KO BM→WT chi-
meric mice (Fig. 6), and asked whether these KO NK cells
would persist in greater numbers after adoptive transfer
into WT versus KO mice. KO NK cells were harvested
Figure 3. Adoptively trans-
ferred splenic NK cells do not
proliferate in the absence of spe-
cific stimuli. (a) Proliferation of
WT NK cells in response to PBS
4 d after transfer into WT host.
Events displayed in histogram
represent transferred CD3 
NK1.1  cells obtained from the
peritoneum of recipient mice.
(b) Proliferation of WT NK cells
in response to IL-15 4 d after
transfer into WT host. (c) Prolif-
eration of WT NK cells in re-
sponse to IL-15 (5  g/day) 4 d
after transfer into KO host.
Figure 4. WT and KO mice express similar amounts of IL-15 mRNA.
Reverse transcriptase-PCR analysis of secreted and nonsecreted forms of
IL-15 mRNA was performed on splenic RNA from mice treated with
poly I:C for the indicated number of days.
Figure 5. Long term survival of transferred WT NK cells in WT
BM→KO radiation BM chimera   WT BM→WT,   WT BM→KO,
  KO BM→KO. Radiation BM chimeric mice were prepared as de-
scribed in Materials and Methods, allowed to recover for at least 8 wk,
and were then used as recipients for WT splenic NK cells. Adoptively
transferred cells were congenic for the radiation sensitive compartment of
the chimeric mice. Data are representative of two experiments, with two
mice each.T
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from spleens of reconstituted KO BM→WT chimera and
transferred into either KO or WT congenic mice. Serial
peripheral blood analyses of these mice revealed that KO
NK cells survive for up to 30 d in WT mice, but disappear
rapidly in KO mice (Fig. 7). Thus, IL-15R  expression on
peripheral NK cells does not mediate the survival signal re-
quired by these cells. This surprising finding indicates that
peripheral NK cell survival is unlikely to be mediated by
the interaction of soluble IL-15 with IL-15R  on the sur-
face of NK cells.
Discussion
In this study, we have investigated the role of IL-15R ,
the high affinity receptor chain for IL-15, in regulating pe-
ripheral NK cells. Our experiments indicate that the sur-
vival of peripheral NK cells is actively maintained by ex-
trinsic signals and that IL-15R  expression on cells other
than NK cells mediates this function. Surprisingly, IL-
15R  expression on NK cells does not mediate this sur-
vival function.
IL-15R  and Peripheral NK Cell Survival. The acute
loss of NK cells after adoptive transfer into KO mice indi-
cates that NK cells must receive tonic extrinsic signals to
survive for even short periods in the periphery. This find-
ing is consistent with a recent study demonstrating a re-
quirement for IL-15 cytokine in supporting peripheral NK
cells (36). However, the prior studies did not distinguish
between the requirement for IL-15R  expression on NK
cells versus other cells. Our experiments show that this
critical function relies upon IL-15R  (in addition to IL-15
and IL-2R ) and is apparent in unperturbed, lymphoid re-
plete animals. It is not dependent upon the induction of
lymphopenic states or radiation-induced cytokines, and is
therefore directly relevant to the physiologic state of rest-
ing animals. This survival function may be related to the
ability of IL-15 to support Bcl-2 expression in NK cells
(19, 36). Hence, in addition to supporting the differentia-
tion of NK cell precursors and the activation and/or prolif-
eration of peripheral NK cells, IL-15R  plays a critical
role in supporting the survival of peripheral NK cells in
unstimulated animals.
IL-15R  /  (KO) NK Cells: Implications for Development
and Peripheral Maintenance. NK cells are markedly de-
pleted ( 2% of normal) in the periphery of IL-15R  / 
(KO) mice (14). Hence, our finding that substantial num-
bers ( 25% of normal) of KO NK cells can differentiate
and persist in KO BM→WT chimeric mice implies that
IL-15R  expression on NK cell precursors is less critical
for NK cell differentiation than was suggested by the virtual
absence of peripheral NK cells in KO mice. While it is pos-
sible that radiation resistant IL-15R  competent BM cells
may also augment the differentiation of KO NK cells in
KO BM→WT chimera, it is more likely that KO NK cells
differentiate comparably in KO BM→KO and KO
BM→WT chimera. When KO NK cells emerge from the
BMs of these chimera, these KO NK cells may survive in
the periphery of KO BM→WT chimera because of the
presence of IL-15R  competent cells, but die in KO
BM→KO chimera. This data also hinted that peripheral
KO NK cells resemble WT NK cells in requiring IL-
15R –dependent cells other than NK cells for survival.
Figure 6. KO NK cells can survive in the peripheral tissues of KO
BM→WT chimera mice. Radiation BM chimeric mice were prepared as
described in Materials and Methods and allowed to recover for at least 8
wk before analysis. (a) Representative FACS® plot of BM-derived NK
cells in spleens of KO BM→WT (top panel) versus KO BM→KO chi-
mera (bottom panel). (b) Percentage of BM derived NK cells obtained
from spleens and peripheral blood of KO BM→WT ( ) and KO
BM→KO ( ) chimera. Data are representative of five mice.
Figure 7. IL-15R  on NK cells is not required for their peripheral
maintenance. Long term serial peripheral blood analysis of adoptively
transferred KO NK cells after transfer into either WT ( ) or KO ( )
hosts. Data are representative of two experiments, with two mice each.T
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982 IL-15R  and Peripheral NK Cell Survival
Thus, in addition to the differential survival of adoptively
transferred peripheral NK cells in WT and KO mice, the
presence of KO NK cells in the periphery of KO
BM→WT chimera provides further evidence that IL-
15R  plays a physiological and critical role in supporting
peripheral NK cell survival.
The presence of significant numbers of KO NK cells in
KO BM→WT chimeric mice also provides novel opportu-
nities to study the functions of IL-15R  on the surface of
peripheral NK cells. While our findings indicate that IL-
15R  expression on NK cells is not required for maintain-
ing survival of resting peripheral NK cells, it remains possi-
ble that IL-15R  expression on NK cells may be required
for NK cell effector functions such as cytolysis or cytokine
secretion. In this context, our finding that IL-15 can stimu-
late WT NK cell proliferation in KO mice suggests that IL-
15R  expression on NK cells could mediate NK cell acti-
vation, cytolytic activity, cytokine elaboration, and/or
proliferation responses during immune challenges in vivo.
Hence, future studies of NK cell responses to viruses and
other immune stimuli in KO BM→WT chimeric mice
will address how IL-15R  expression on NK cells may
regulate these functions.
NK Cell–independent IL-15R  Expression and Peripheral
NK Cell Survival. The finding that IL-15R  expression
on cells other than NK cells support peripheral NK cell
survival prompts reevaluation of the mechanism(s) by
which IL-15R  may support NK cells. The loss of NK
cells after transfer into KO mice could theoretically reflect
loss of IL-15R –dependent cells and/or loss of tonic IL-
15R  signals. Depletion of peripheral NK cells by repeated
injections of anti-IL-2R  specific Fab’ fragments suggested
that tonic IL-15R  signals in mature cells may be the pri-
mary mechanism maintaining NK cells (36).
IL-15R  mRNA is expressed in most tissues and is
thought to be expressed in multiple cell types (4). Thus, the
IL-15R  dependent cell types that support NK cells may
include multiple hematopoietic or nonhematopoietic cells.
The fact that WT BM→KO chimera possess mature NK
cells demonstrates that BM derived hematopoietic cells
support these cells in the periphery. The finding that WT
BM→KO chimera support fewer peripheral NK cells than
WT BM→WT chimera suggests that nonhematopoietic
stromal cells might also serve this function. However, we
cannot definitively confirm a role for nonhematopoietic
cells since rare hematopoietic cells can survive the lethal ir-
radiation protocols we have used. In addition, the presence
of largely normal numbers of peripheral NK cells in both
RAG-1 /  and RAG-2 /  mice suggest that adaptive T
and B lymphocytes do not play a major role in supporting
basal NK cell survival. Thus, one may deduce that the IL-
15R –dependent cells that support NK cell survival in-
clude nonlymphoid hematopoietic cells.
The IL-15R –dependent factor that supports NK cells is
unclear. Because prior data suggested that heterologous IL-
15 could directly support these cells, we investigated the
possibility that KO mice might express less IL-15 than nor-
mal mice. Multiple posttranscriptional and posttranslational
mechanisms regulate IL-15 protein secretion (33, 34, 37),
indicating that the measurement of endogenous IL-15 pro-
tein levels would be the preferable means of addressing this
question. However, in the absence of reliable antibody re-
agents for detecting endogenous murine IL-15 protein, we
are left with measurements of the preferentially secreted
isoforms of IL-15 mRNA. As we detected similar levels of
mRNA specific for these IL-15 isoforms, we have no evi-
dence that KO mice secrete less IL-15 than normal mice.
Indeed, if IL-15 was secreted at roughly normal levels in
IL-15R  /  mice, then one would intuitively expect that
the amount of soluble IL-15 would be present at far greater
levels in these mice since no high affinity receptors would
be present to bind IL-15. Moreover, our observation that
adoptively transferred KO NK cells, presumably unable to
bind soluble IL-15, survive in WT but not KO mice is not
consistent with the hypothesis that reduced levels of soluble
IL-15 cause less IL-15R –mediated stimulation of NK
cells in KO mice (see below). Other cytokines that share
the  c receptor, such as IL-2, IL-4, and IL-7, can support
NK cells, and we have observed similar levels of mRNA
specific for these cytokines in KO mice. This observation,
combined with the largely normal numbers of NK cells in
mice deficient for these cytokines or their receptors suggest
that these other cytokines do not support peripheral NK
cell survival. It is also possible that IL-15R  expression on
cells other than NK cells could mediate the stimulation of
other unidentified soluble or membrane bound factors that
directly stimulate NK cell survival.
IL-15R  Expression on NK Cells and Peripheral NK Cell
Survival. Our finding that IL-15R  expression on cells
other than NK cells regulates the survival of peripheral NK
cells did not address whether IL-15R  expression on NK
cells may also contribute to this function. Indeed, prior ev-
idence that IL-15R  alone binds IL-15 with high affinity
and that soluble IL-15 can stimulate mature NK cell sur-
vival and proliferation led to the widespread presumption
that IL-15R  on the surface of NK cells should mediate
NK cell responses to IL-15. However, our observation that
adoptively transferred KO NK cells survive well in WT but
not KO mice indicates that IL-15R  expression on NK
cells does not regulate this process. Thus, the stereotypical
interaction of soluble IL-15 with IL-15R /IL-2R / c tri-
meric receptors on NK cells is unlikely to be the signal that
supports NK cell survival in unchallenged animals.
One intriguing possible mechanism of IL-15R ’s action
is raised by a recent study indicating that IL-15R  can
present IL-15 in trans to other cells bearing IL-15R  and
 c receptor chains (38). In this context, membrane bound
IL-15 has been documented on multiple cell types (39, 40).
Thus, if IL-15R  on the surface of non-NK cells bound
IL-15 and presented this cytokine to IL-2R  and  c receptor
chains on NK cells, then IL-15R  expression on non-NK
cells could be required for NK cell survival. In this sce-
nario, IL-15R  expression on NK cells would also be dis-
pensable. Other possible explanations for IL-15R ’s indi-
rect role in regulating NK cell survival could include other
IL-15R  induced genes in accessory cells.T
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Recent studies indicate that CD8  memory phenotype
T cells, antigen-specific memory CD8  T cells, and CD1-
restricted NKT cells all require IL-15 or IL-15R  for sur-
vival and/or proliferation in peripheral tissues (6, 41, 42,
43, 44). Their common dependence upon IL-15 or IL-
15R  has led to the suggestion that IL-15 bioavailability
may comprise a biological niche shared by these diverse
cell types. If substantiated by further studies, this concept
could provide a novel mechanism by which innate and
adaptive immune responses can be coordinated and regu-
lated. Nevertheless, when combined with prior observa-
tions that CD8  T cell proliferation is indirectly regulated
by IL-15R  signals (25), our current data definitively
demonstrate that a critical role for IL-15R  expression
exists on cells other than the responding lymphocytes, and
that IL-15R  expression on NK cells as well as CD8  T
cells does not mediate the survival and proliferation signals
ascribed to IL-15. Thus, a simple pool of soluble IL-15
that is shared by various immune cell types is unlikely to
mediate this niche. These surprising findings not only
force a reevaluation of how IL-15 and IL-15R  regulate
the homeostasis of both innate and adaptive immune cells,
but also provide novel insights into the mechanisms of
immune homeostasis.
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